4//SEC Filing
CHASE RANDAL D 4
Accession 0001437749-21-019504
CIK 0000832489other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 5:33 PM ET
Size
5.6 KB
Accession
0001437749-21-019504
Insider Transaction Report
Form 4
CHASE RANDAL D
Director
Transactions
- Award
Stock Option (right to buy)
2021-08-11+25,000→ 25,000 totalExercise: $2.79Exp: 2030-12-02→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.
- [F2]Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
Documents
Issuer
GeoVax Labs, Inc.
CIK 0000832489
Entity typeother
Related Parties
1- filerCIK 0001078784
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 5:33 PM ET
- Size
- 5.6 KB